Search clinical trials for: prednisone plus cyclophosphamide

Total 10297 results

University of Alabama at Birmingham
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy

Myasthenia Gravis

Thailand, Canada, Germany, Italy, Netherlands, Brazil, United States, Argentina, Australia, Chile, Japan, Mexico, Poland, Portugal, South Africa, Spain, Taiwan, United Kingdom
Guangdong Provincial People's Hospital

Unknown

Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy (TOPplus-IgAN)

IgA Nephropathy

China
Nanjing University School of Medicine

Completed

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

IgA Nephropathy

China
Hoffmann-La Roche

Completed

A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma

Hong Kong, Germany, Philippines, Taiwan, Turkey, Canada, Australia, Austria, New Zealand, Thailand, Hungary, Italy, Korea, Republic of, Romania, Netherlands, Brazil, Indonesia, Croatia, Egypt, Portugal, Sweden, Colombia, Argentina, De... and more
Indiana University School of Medicine

Completed

A Comparison of Three Different Formulations of Prednisolone Acetate 1%

Glaucoma | Cataract

United States
Celgene

Completed

A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

Sarcoidosis, Pulmonary

United States, United Kingdom, Netherlands
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years (CORTAGE)

Vasculitis | Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome | Polyarteritis Nodosa

France
Air Force Military Medical University, China

Recruiting

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

Glomerulonephritis, IGA

China
IRCCS Policlinico S. Matteo

Completed

Prospective Study on Intensive Early Rheumatoid Arthritis Treatment (CURE)

Rheumatoid Arthritis

Italy
ChemoCentryx

Completed

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

ANCA-associated Vasculitis

United States, Canada
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Lymphoproliferative Disorder

Canada, United States, Australia, New Zealand
University of Nebraska
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Lymphoma

United States
Bristol-Myers Squibb

Withdrawn

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Melanoma | Renal Cell Carcinoma | Lung Cancer

United States
Lawson Health Research Institute

Completed

Pilot Study of How Children With Asthma Exacerbations Metabolize Prednisone

Asthma Exacerbation

Canada
Nagasaki University

Unknown

Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery

Esophageal Anastomotic Stricture

Japan
University of California, San Francisco
Medical University of South Carolina; M.D. Anderson Cancer Center; University... and other collaborators

Enrolling by invitation

Focal Cerebral Arteriopathy Steroid Trial (FOCAS)

Arterial Ischemic Stroke | Pediatric Stroke | Arteriopathy

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute

Recruiting

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Melanoma Stage IV | Melanoma Stage III | Drug Toxicity | Immune-related Adverse Event | Skin Cancer Stage III | Skin Cancer Stage IV | Drug-Induced Colitis

United States
Guangdong Provincial People's Hospital

Unknown

Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy (e-TOPplus)

IgA Nephropathy

China
Ruijin Hospital

Unknown

A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy

Graves' Ophthalmopathy

China
ACELYRIN Inc.

Completed

A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis (LINNAEA)

Uveitis

United States
GlaxoSmithKline

Completed

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Asthma

United States, Australia, Canada, France, Germany, Netherlands, Poland, Mexico, United Kingdom, Czech Republic
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Multiple Myeloma

Italy
Massachusetts Eye and Ear Infirmary
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

Sudden Deafness Treatment Trial (SSNHL)

Sudden Deafness

United States
UMC Utrecht
Celgene Corporation

Completed

Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT) (REPEAT)

Multiple Myeloma

Netherlands
Medical University of Lodz

Recruiting

Effect of Glucocorticoids on Inflammation and Bone Metabolism in Patients With Glomerular Disease

Glomerular Disease

Poland
Incyte Corporation

Completed

A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Graft-versus-host Disease (GVHD)

United States
Eye & ENT Hospital of Fudan University

Unknown

Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids

Sudden Hearing Loss | Vestibular Vertigo

China
Janssen Research & Development, LLC

Completed

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Postmenopausal | Metastatic ER+ Her2- Breast Cancer

United States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
Janssen Research & Development, LLC

Approved for marketing

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Metastatic Castration-resistant Prostate Cancer

Brazil, Austria, Estonia, Israel, Mexico
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

Head and Neck Carcinoma | Oropharyngeal Carcinoma | Cranial Nerve Disorder

United States
Rutgers, The State University of New Jersey

Terminated

Dose of Corticosteroids in COPD (DOSE)

COPD

United States
Centre hospitalier de l'Université de Montréal...
Genzyme, a Sanofi Company

Active, not recruiting

Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide (CABPOSTAAT)

Metastatic Prostate Cancer

Canada
Christine Mauz-Körholz
Deutsche Krebshilfe e.V., Bonn (Germany); Euronet Worldwide

Completed

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Lymphoma

United Kingdom, Germany
Assiut University

Completed

Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy

Facial Palsy
Eli Lilly and Company

Active, not recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (CYCLONE 3)

Urogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditions

China, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
Sanofi

Completed

Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer (PROSELICA)

Prostate Cancer

Korea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
VA Office of Research and Development

Recruiting

Dynamic Treatment Regiments for Glucocorticoid Tapering (SMART-RA)

Rheumatoid Arthritis

United States
Incyte Corporation

Completed

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Graft-versus-host Disease (GVHD)

United States
Sun Yat-sen University

Recruiting

Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer (Increase)

Breast Cancer

China
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

Recurrent Adult Acute Lymphoblastic Leukemia | Graft Versus Host Disease

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

Anti-inflammatory Treatment for Inactive Takayasu Arteritis (ATITA)

Takayasu Arteritis | Anti-Inflammatory Agents
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease

Graft Versus Host Disease

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host...

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma

Asthma

China, India
Shanghai University of Traditional Chinese Medicine
RenJi Hospital; Shanghai 6th People's Hospital

Unknown

Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath

IgA Nephropathy

China
Sanofi
Regeneron Pharmaceuticals

Active, not recruiting

Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

Asthma

Mexico, Spain, Argentina, Japan, Poland, United States, Turkey, Australia, Brazil, Canada, Chile, Colombia, Hungary, Italy, Lithuania, Russian Federation, South Africa, Ukraine
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Severe Erythema Multiforme - CORTICO (SEMCORTICO)

Erythema Multiforme
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...

Active, not recruiting

Pharmacogenomics IND EXEMPT SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms (Drugs-SNPs)

Prostate Cancer

United States
Incyte Corporation

Terminated

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Chronic Graft-versus-host Disease

United States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
Incyte Corporation

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Chronic Graft-versus-host-disease

Search clinical trials for: prednisone plus cyclophosphamide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations